Gastrointestinal Stromal Tumors, Intramural Leiomyomas, and Leiomyosarcomas in the Duodenum: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 167 Cases

&NA; In this study we analyzed the clinicopathologic features of duodenal smooth muscle or stromal tumors, including 156 GISTs, 6 leiomyomas (LMs), and 5 leiomyosarcomas (LMSs) from the files of the Armed Forces Institute of Pathology and the Haartman Institute of the University of Helsinki. GISTs were documented as KIT positive (n = 109); 47 tumors were also included because of their histologic identity to KIT‐positive cases. GIST‐specific c‐kit gene mutations were documented in exon 11 in 9 of 30 cases (30%) and exon 9 in 4 of 30 cases (13%). The GISTs occurred in patients with an age range of 10–88 years (median 56 years); 54% were male. Ten patients had neurofibromatosis type I; six of them had multiple GISTs. The GISTs ranged from small asymptomatic intramural or external nodules to large masses that extended into the retroperitoneum (median size 4.5 cm). They were mostly spindle cell tumors; three malignant GISTs had an epithelioid morphology, and 81 cases had skeinoid fibers. The tumors often coexpressed CD34 and KIT (54%) and were variably positive for smooth muscle actin (39%) and S‐100 protein (20%) but never for desmin. A total of 86% of patients with tumors >5 cm with >5 mitoses/50 high power fields (HPF) (n = 21) died of disease, whereas no tumor <2 cm with <5 mitoses/50 HPF (n = 12) recurred or caused death. Long latency was common between primary operation and recurrences or metastases; either one occurred in 49 of 140 patients with follow‐up (35%). No formula could accurately predict metastases, which occasionally developed even if mitotic activity was <5/50 HPF and size <5 cm. Metastases were in the abdominal cavity, liver, and rarely in bones and lungs but never in lymph nodes. Four actin‐ and desmin‐positive and KIT‐negative benign intramural LMs were similar to those more often seen in the esophagus. There were five LMSs, one of which formed a polypoid intraluminal mass; all were actin positive and KIT negative. The great majority of duodenal mesenchymal tumors are GISTs, which have a spectrum from small indolent tumors to overt sarcomas. LMs and LMSs are rare.

[1]  A. D. Van den Abbeele,et al.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. , 2002, The New England journal of medicine.

[2]  G. Demetri,et al.  Clinical management of gastrointestinal stromal tumors: before and after STI-571. , 2002, Human pathology.

[3]  C. J. Chen,et al.  KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. , 2001, Cancer research.

[4]  D. Tuveson,et al.  Signal transduction pathways in sarcoma as targets for therapeutic intervention , 2001, Current opinion in oncology.

[5]  L. Sobin,et al.  Schwannomas in the Colon and Rectum: A Clinicopathologic and Immunohistochemical Study of 20 Cases , 2001, The American journal of surgical pathology.

[6]  B. Druker,et al.  Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. , 2000, The Journal of pharmacology and experimental therapeutics.

[7]  L. Sobin,et al.  Gastrointestinal Stromal Tumors and Leiomyosarcomas in the Colon: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 44 Cases , 2000, The American journal of surgical pathology.

[8]  L. Sobin,et al.  Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases. , 2000, The American journal of pathology.

[9]  L. Sobin,et al.  Immunohistochemical Spectrum of GISTs at Different Sites and Their Differential Diagnosis with a Reference to CD117 (KIT) , 2000, Modern Pathology.

[10]  J. Lasota,et al.  KIT Expression in Angiosarcomas and Fetal Endothelial Cells: Lack of Mutations of Exon 11 and Exon 17 of C-kit , 2000, Modern Pathology.

[11]  R. Foster,et al.  Tumors of the Rectum and Anal Canal , 2000, World Journal of Surgery.

[12]  R. Yantiss,et al.  Neoplastic and pre-neoplastic changes in gastrointestinal endometriosis: a study of 17 cases. , 2000, The American journal of surgical pathology.

[13]  J. Fletcher,et al.  KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. , 2000, The American journal of pathology.

[14]  L. Sobin,et al.  Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. , 2000, The American journal of surgical pathology.

[15]  S. Hirota,et al.  Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. , 1999, Cancer research.

[16]  J. Goldblum,et al.  Stromal tumors of the anorectum: a clinicopathologic study of 22 cases. , 1999, The American journal of surgical pathology.

[17]  C. Marshall,et al.  Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors , 1999, Oncogene.

[18]  L. Kindblom,et al.  Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. , 1998, The American journal of pathology.

[19]  S. Hirota,et al.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. , 1998, Science.

[20]  S. Suster.  Gastrointestinal stromal tumors. , 1996, Seminars in diagnostic pathology.

[21]  S. Haque,et al.  Stromal neoplasms of the rectum and anal canal. , 1992, Human pathology.

[22]  M. Enjoji,et al.  A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors , 1992, Cancer.

[23]  K. Min,et al.  Small Intestinal Stromal Tumors With Skeinoid Fibers: Clinicopathological, Immunohistochemical, and Ultrastructural Investigations , 1992, The American journal of surgical pathology.

[24]  L. Tan,et al.  Colorectal smooth-muscle tumors. A pathobiologic study with immunohistochemistry and histomorphometry. , 1991, Archives of pathology & laboratory medicine.

[25]  M. Enjoji,et al.  Benign schwannoma of the gastrointestinal tract: a clinicopathologic and immunohistochemical study. , 1988, Human pathology.

[26]  C. Mann,et al.  Smooth muscle neoplasms of the rectum and anal canal , 1984, The British journal of surgery.

[27]  R. Kusminsky,et al.  Leiomyomas of the rectum and anal canal: Report of six cases and review of the literature , 1977, Diseases of the colon and rectum.

[28]  J. Stoeckinger,et al.  Smooth-muscle rectal tumors: A therapeutic dilemma , 1977, Diseases of the colon and rectum.

[29]  J. L. Hill,et al.  Leiomyosarcoma of the duodenum in a 10-year-old boy. , 1976, Pediatrics.

[30]  M. Ishida,et al.  Smooth-muscle tumors of the rectum in Japanese , 1974, Diseases of the colon and rectum.

[31]  V. Kořístek,et al.  [TUMORS OF THE SMALL INTESTINE]. , 1963, Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti.

[32]  C. Antignac,et al.  Diffuse esophageal leiomyomatosis with perirectal involvement mimicking Hirschsprung disease. , 2001, Gastroenterology.

[33]  J. Lasota,et al.  Gastrointestinal stromal tumors – definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis , 2000, Virchows Archiv.

[34]  J. Lasota,et al.  Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. , 1999, The American journal of pathology.

[35]  S. Hirota,et al.  Molecular pathology of c-kit proto-oncogene and development of gastrointestinal stromal tumors. , 1998, Annales chirurgiae et gynaecologiae.

[36]  J. Goldblum,et al.  Stromal tumors of the duodenum. A histologic and immunohistochemical study of 20 cases. , 1995, The American journal of surgical pathology.